Par Drugs and Chemicals Limited (NSE:PAR)

Par Drugs and Chemicals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	418.43	275.77	366.54	222.43	162.06
Cash & Short-Term Investments	418.43	418.43	275.77	366.54	222.43	162.06
Cash Growth	51.73%	51.73%	-24.76%	64.79%	37.25%	-23.42%
Accounts Receivable	-	120.28	167.14	137.14	169.69	184.67
Other Receivables	-	-	-	-	-	0.74
Receivables	-	121.39	168.13	138.09	170.45	185.91
Inventory	-	53.73	61.94	44.21	59.68	54.98
Prepaid Expenses	-	-	0.33	0.37	0.43	0.48
Other Current Assets	-	49.71	42.44	47.02	41.38	32.2
Total Current Assets	-	643.26	548.61	596.24	494.37	435.64
Property, Plant & Equipment	-	371.56	389.15	413.35	386.95	343.51
Long-Term Investments	-	271.36	250.7	0.12	0.1	0.1
Other Long-Term Assets	-	5.94	5.44	6.41	7.26	7.65
Total Assets	-	1,292	1,194	1,016	888.68	786.9

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	81.94	108.91	53.56	80.92	106.62
Accrued Expenses	-	-	6.28	21	20.4	8.41
Current Income Taxes Payable	-	-	45.25	49.76	37.95	33.45
Current Unearned Revenue	-	-	5.23	0.05	0.62	0.09
Other Current Liabilities	-	55.5	0.02	0.02	0	0
Total Current Liabilities	-	137.44	165.69	124.39	139.89	148.57
Pension & Post-Retirement Benefits	-	2.4	2.67	-	1.4	4.06
Long-Term Deferred Tax Liabilities	-	32.44	35.8	35.4	35	35.5
Other Long-Term Liabilities	-	-	0	-	-	-
Total Liabilities	-	172.28	204.15	159.79	176.3	188.13

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	123.05	123.05	123.05	123.05	123.05
Additional Paid-In Capital	-	-	106.73	106.73	106.73	106.73
Retained Earnings	-	-	759.29	625.86	481.93	368.31
Comprehensive Income & Other	-	996.8	0.69	0.69	0.69	0.69
Total Common Equity	1,120	1,120	989.75	856.32	712.38	598.77
Shareholders' Equity	1,120	1,120	989.75	856.32	712.38	598.77
Total Liabilities & Equity	-	1,292	1,194	1,016	888.68	786.9

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash (Debt)	418.43	418.43	275.77	366.54	222.43	162.06
Net Cash Growth	51.73%	51.73%	-24.76%	64.79%	37.25%	26.19%
Net Cash Per Share	34.01	33.99	22.41	29.79	18.08	13.17
Filing Date Shares Outstanding	12.3	12.37	12.3	12.3	12.3	12.3
Total Common Shares Outstanding	12.3	12.37	12.3	12.3	12.3	12.3
Working Capital	-	505.82	382.93	471.84	354.48	287.07
Book Value Per Share	90.52	90.52	80.44	69.59	57.90	48.66
Tangible Book Value	1,120	1,120	989.75	856.32	712.38	598.77
Tangible Book Value Per Share	90.52	90.52	80.44	69.59	57.90	48.66
Land	-	-	31.48	31.48	6.21	3.32
Buildings	-	-	202.81	198.21	183.18	152.36
Machinery	-	-	463.15	459.94	443.59	413.09
Construction In Progress	-	-	-	0.25	2.45	2.48

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error